iShares iBoxx $ High Yield Corporate Bond ETF vs Regeneron Pharmaceuticals Inc — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.57, while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc pays a 0.47% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and Regeneron Pharmaceuticals Inc is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| HYG | REGN | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $81.32 | $812.27 |
52-Week Low | $78.72 | $555.51 |
Market Cap | — | $82.06B |
Enterprise Value | — | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →